Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

February 19, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

September 30, 2021

Conditions
Covid19
Interventions
DRUG

3-dayIVM 200 mcg/kg/day/14-day 75mgASA/day + standard of care (intervention 1)

Low dose aspirin for 14 days plus ivermectin at 200 mcg/kg/day or 600 mcg/kg/day for 3 days

Sponsors
All Listed Sponsors
collaborator

Ministry of Health, Uganda

OTHER_GOV

collaborator

Mbarara University of Science and Technology

OTHER

collaborator

Joint Clinical Research Center

OTHER

lead

Makerere University

OTHER